蔡舟,王憲偉,黃建華,劉光強(qiáng),王偉,王志明
(中南大學(xué)湘雅醫(yī)院 普通外科,湖南 長(zhǎng)沙 410008)
隨著經(jīng)濟(jì)和醫(yī)療水平的發(fā)展,靜脈曲張?jiān)絹?lái)越受到重視,目前治療靜脈曲張的傳統(tǒng)方法也多各有特點(diǎn),如內(nèi)翻抽剝、外翻抽剝、點(diǎn)式抽剝、分段抽剝、膝上抽剝及單純的大隱靜脈高位結(jié)扎等。其中內(nèi)翻抽剝可以從近心端開(kāi)始往遠(yuǎn)心端抽剝[1-2],也可以從遠(yuǎn)心端開(kāi)始往近心端抽剝[2-3],目前關(guān)于兩者的療效比較的研究較少。因此,本中心總結(jié)了2010—2014年在中南大學(xué)湘雅醫(yī)院行內(nèi)翻抽剝加點(diǎn)式抽剝治療大隱靜脈曲張的患者511例,并根據(jù)其內(nèi)翻抽剝方向的不同,定義將從內(nèi)踝附近開(kāi)始(遠(yuǎn)心端)抽剝至隱股交界處(近心端)的抽剝方式命名為順行抽剝[2,4]。同理,從隱股交界處(近心端)開(kāi)始抽剝至內(nèi)踝附近(遠(yuǎn)心端)的抽剝方式為逆行抽剝[2],分析不同抽剝方向?qū)颊咝g(shù)中術(shù)后的影響及預(yù)后,結(jié)果報(bào)告如下。
2012—2014 年中南大學(xué)湘雅醫(yī)院總共完成大隱靜脈高位結(jié)扎+內(nèi)翻抽剝+點(diǎn)狀抽剝511例,其中采用順行抽剝2 3 4例(順行組),逆行抽剝2 7 7例(逆行組)。順行組:男1 0 3例,女131例;年齡39~74歲,平均(52.6±5.1)歲;病程5~2 1年,平均(1 0.8±4.3)年。逆行組:男1 1 4例,女1 6 3例;年齡3 6~7 2歲,平均(5 6.2±5.3)歲;病程5~2 5年,平均(9.6±6.7)年。兩組CEAP分級(jí)[5]情況見(jiàn)表1。兩組患者術(shù)前均經(jīng)彩色多普勒超聲檢查[6-7],且性別、年齡、CEAP分級(jí)[5]等方面均無(wú)統(tǒng)計(jì)學(xué)差異(均P>0.05),具有可比性。
納入標(biāo)準(zhǔn):有明確的靜脈曲張病史,靜脈曲張明顯(C3~C6級(jí))。下肢大隱靜脈瓣膜功能試驗(yàn)提示大隱靜脈瓣膜功能不全,下肢深靜脈通暢試驗(yàn)提示深靜脈通暢。合并下肢腫脹或有單側(cè)下肢腫脹病史者行下肢筋脈造影[7]。排除標(biāo)準(zhǔn):所有患者術(shù)前B超檢查排除深靜脈血栓、深靜脈閉塞、KliPPel-Trenaunay綜合征、深靜脈返流、髂靜脈卡壓綜合征等深靜脈疾病[8];
表1 兩組患者CEAP分級(jí)構(gòu)成[n(%)]Table 1 Constitutions of the CEAP grades in the two groups of patients [n (%)]
手術(shù)時(shí)間:從皮膚切開(kāi)開(kāi)始計(jì)時(shí)至皮膚縫合結(jié)束;術(shù)中出血量,術(shù)后血腫情況,隱神經(jīng)損傷情況(小腿內(nèi)踝區(qū)皮膚麻木感)[9-10],術(shù)后住院時(shí)間,術(shù)后深靜脈血栓形成[11],靜脈曲張復(fù)發(fā)基于以下檢查:彩色多普勒超聲檢查和下肢靜脈造影,Valsalva試驗(yàn)觀察下肢靜脈血液反流程度[12-13]。
術(shù)前讓患者取站立位,水性標(biāo)記筆標(biāo)記曲張明顯部位,包括各屬支及血栓部位。取卵圓窩處2 cm小切口,鈍性分離暴露大隱靜脈主干,距隱-股靜脈約0.5 cm處將大隱靜脈主干切斷,近端進(jìn)行結(jié)扎并縫扎,遠(yuǎn)端備用。再取內(nèi)踝前1.5 cm處8 mm小切口,切斷大隱靜脈起始端,遠(yuǎn)端結(jié)扎,兩組均從近端順行插入法國(guó)God-line抽剝導(dǎo)管,導(dǎo)管貫穿整個(gè)大隱靜脈,逆行組將導(dǎo)管中段抽剝器固定于隱股交界處?kù)o脈斷端(圖1A),從隱股交界處往遠(yuǎn)心端牽拉抽剝導(dǎo)管;順行組將導(dǎo)管中段抽剝器固定于內(nèi)踝處?kù)o脈斷端(圖1B),從內(nèi)踝處往近心端牽拉抽剝導(dǎo)管。中途斷裂者加行斷裂處小切口繼續(xù)完成抽剝,直至整條靜脈完整抽出。另于靜脈曲張明顯屬支處做5~8 mm小切口,抽剝曲張明顯的屬支。術(shù)后彈力繃帶加壓包扎至傷口愈合。
圖1 抽剝器固定方式 A:逆行抽剝;B:順行抽剝Figure 1 Modes of vein stripper fi xation A: Retrograde stripping ; B: Anterograde stripping
插入導(dǎo)管時(shí),需要用肝素水潤(rùn)濕導(dǎo)管(250 mL生理鹽水+25 mg肝素)。術(shù)后建議低分子肝素抗凝治療1周防止深靜脈血栓形成[14-15]。傷口愈合后改穿彈力襪半年至1年。
順行組與逆行組患者的手術(shù)時(shí)間、術(shù)中出血量、切口個(gè)數(shù)以及術(shù)后住院時(shí)間差異均無(wú)統(tǒng)計(jì)學(xué)意義(均P>0.05)(表2)。
表2 兩組患者術(shù)中指標(biāo)及住院時(shí)間比較(±s)Table 2 Comparison of the intraoperative variables and length of postoperative hospitalization between the two groups of patients (±s)
表2 兩組患者術(shù)中指標(biāo)及住院時(shí)間比較(±s)Table 2 Comparison of the intraoperative variables and length of postoperative hospitalization between the two groups of patients (±s)
組別 n 手術(shù)時(shí)間(min) 術(shù)中失血量(mL) 切口個(gè)數(shù) 術(shù)后住院時(shí)間(d)順行組 234 32.6±4.4 22.7±6.4 3.8±0.8 2.56±1.7逆行組 277 34.1±5.1 23.5±5.7 4.1±0.7 2.81±1.6 t -2.733 -2.269 -3.511 -2.044 P 0.11 0.08 0.23 0.31
順行組與逆行組術(shù)后血腫、深靜脈血栓形成發(fā)生率、總并發(fā)癥發(fā)生率均無(wú)統(tǒng)計(jì)學(xué)差異(均P>0.05);但順行組的隱神經(jīng)損傷發(fā)生率明顯低于逆行組(P<0.05)(表3)。
表3 兩組患者的術(shù)后總并發(fā)癥情況比較[n(%)]Table 3 Comparison of the postoperative complications [n(%)]
有12例慢性潰瘍形成患者,潰瘍面積減小,1例行植皮手術(shù)(郵票皮)后治愈。逆行組平均術(shù)后潰瘍愈合時(shí)間(48.5±10.4)d,順行組平均術(shù)后潰瘍愈合時(shí)間(54±14.6)d,兩組比較,差異無(wú)統(tǒng)計(jì)學(xué)意義(t=1.77,P>0.05)。
對(duì)482例患者進(jìn)行了1~3年的門(mén)診及或電話隨訪,其中隨訪率81.74%,失訪率18.26%。數(shù)據(jù)顯示,順行組與逆行組患者術(shù)后酸脹感發(fā)生率差異無(wú)統(tǒng)計(jì)學(xué)意義(P>0.05),但術(shù)后靜脈曲張復(fù)發(fā)率明顯低于逆行組(P<0.05)(表4)。
表4 兩組患者術(shù)后酸脹感及靜脈曲張復(fù)發(fā)情況比較(%)Table 4 Comparison of the leg acid bilges and recurrence of varicose veins in the two groups of patients (%)
大隱靜脈曲張為我國(guó)的常見(jiàn)病及多發(fā)病,特別是在農(nóng)村地區(qū),許多患者往往是因皮膚潰爛或血栓形成而就診[16]。目前國(guó)內(nèi)外對(duì)于大隱靜脈曲張的治療方式多種多樣,包括傳統(tǒng)手術(shù)、液體或泡沫硬化、射頻、激光、彈力襪保守治療等[17]。隨著治療方式的多樣化及多元化,許多學(xué)者提出許多創(chuàng)新的治療方法,但有循證醫(yī)學(xué)資料證實(shí),外科手術(shù)仍是治療大隱靜脈曲張的首選方法[9]。大隱靜脈抽剝?yōu)閭鹘y(tǒng)的手術(shù)方法,有學(xué)者[18-20]對(duì)其進(jìn)行了改進(jìn)。該手術(shù)由于創(chuàng)傷小,并發(fā)癥少,適應(yīng)范圍廣而得到廣泛運(yùn)用。我科根據(jù)多年的臨床經(jīng)驗(yàn),對(duì)其治療方法做了進(jìn)一步細(xì)化處理。
以上結(jié)果提示,順行抽剝與逆行抽剝兩者在手術(shù)時(shí)間、術(shù)中出血量、平均切口個(gè)數(shù)及術(shù)后住院時(shí)間上沒(méi)有明顯差異,說(shuō)明兩組在技術(shù)難度方面沒(méi)有明顯差異。但術(shù)后并發(fā)癥情況的比較提示順行抽剝的效果明顯優(yōu)于逆行抽剝。筆者考慮其原因可能如下:首先順行抽剝時(shí),其抽剝方向朝向近心端,而靜脈屬支的分布方向也是如此,其對(duì)周圍組織的破壞較逆向剝離小。其次順行抽剝時(shí),每次需要?jiǎng)冸x的分支血管,僅僅是剝離器周圍的2~3支屬支,而逆式剝離時(shí),需要同時(shí)扯動(dòng)所有屬支血管,故而順行抽剝比較容易。第三由于順行抽剝時(shí)用力僅牽扯抽剝器周圍的屬支,故而創(chuàng)傷更小,對(duì)隱神經(jīng)的影響更小,術(shù)后發(fā)生皮下水腫、疼痛等的幾率更小,患者及家屬更加容易接受,術(shù)后糾紛更少。
手術(shù)治療下肢靜脈曲張,皮神經(jīng)損傷的發(fā)生率高達(dá)6%~53%[3,21-22],而本研究入組患者發(fā)生隱神經(jīng)損傷并發(fā)癥比例極低,主要是因?yàn)閮?nèi)翻式抽剝對(duì)于完整剝脫大隱靜脈患者損傷小;其次,點(diǎn)式抽剝時(shí)盡量避開(kāi)腘靜脈血管叢周圍及大隱靜脈主干,仔細(xì)分離需要點(diǎn)式抽剝的血管,做到只抽剝血管;第三,盡量減少剝離子的運(yùn)用,從而減輕對(duì)隱神經(jīng)的損傷。
大隱靜脈曲張術(shù)后較嚴(yán)重的并發(fā)癥主要是下肢深靜脈血栓形成及肺栓塞[23-24]。Wang等[25]的研究結(jié)果顯示低分子肝素能夠預(yù)防術(shù)后DVT形成。本研究提示順行插管組深靜脈血栓發(fā)生率稍高于逆行插管組,兩者無(wú)明顯統(tǒng)計(jì)學(xué)差異,考慮術(shù)中肝素化處理導(dǎo)管及術(shù)后抗凝治療有一定的作用。
靜脈曲張術(shù)后復(fù)發(fā)的主要原因有:殘端過(guò)長(zhǎng)、大隱靜脈部分再通或完整存在、大隱靜脈主干部分殘留、小隱靜脈曲張、髂靜脈壓迫等[26]。本研究中兩組術(shù)后患者遠(yuǎn)期靜脈曲張復(fù)發(fā)比例均較低,取得了比較好的效果,兩者復(fù)發(fā)情況有明顯差異,目前兩者差異原因不明。 考慮可能與以下因素有關(guān):⑴ 順行抽剝術(shù)后將買抽剝較完整;⑵ 順行抽剝術(shù)后主干殘留可能更少;⑶ 順行組小隱靜脈抽剝更徹底;因本研究屬于回顧性研究,病例材料缺乏相應(yīng)的統(tǒng)計(jì),其具體原因需要進(jìn)一步研究。
綜上所述,對(duì)于內(nèi)翻抽剝治療大隱靜脈曲張,順行抽剝治療療效優(yōu)于逆行抽剝治療。
[1]李春雷, 費(fèi)伯健, 王泉興, 等. 高位結(jié)扎聯(lián)合點(diǎn)狀剝脫術(shù)治療大隱靜脈曲張的療效分析[J]. 江蘇醫(yī)藥, 2014, 40(24):3053–3054.Li CL, Fei BJ, Wang QX, et al. Ef fi cacy analysis of high ligation plus dot stripping in treatment of great saphenous varicose veins[J].Jiangsu Medical Journal, 2014, 40(24):3053–3054.
[2]盧欽榮, 李思榮, 盧裕, 等. 大隱靜脈高位結(jié)扎+主干順行抽剝+分支曲張靜脈泡沫硬化劑注射療法治療下肢大隱靜脈曲張的臨床研究[J]. 中國(guó)當(dāng)代醫(yī)藥, 2016, 23(9):48–50.Lu QR, Li SR, Lu Y, et al. Clinical research of great saphenous vein high ligation of main trunk+direct extraction stripping+branch varicose vein foam sclerosing agent injection therapy in the treatment of lower limb varicosis of great saphenous vein[J]. China Modern Medicine, 2016, 23(9):48–50.
[3]秦晶, 趙子夜, 梅志軍. 改良內(nèi)翻抽剝法預(yù)防大隱靜脈剝脫術(shù)中隱神經(jīng)損傷[J]. 外科理論與實(shí)踐, 2012, 17(2):157–159.doi:10.3969/j.issn.1007–1096.2012.02.016.Qin J, Zhao ZY, Mei ZJ. Prevention of saphenous nerve injury by modi fi ed invaginated stripping of great saphenous vein[J]. Journal of Surgery Concepts & Practice, 2012, 17(2):157–159. doi:10.3969/j.issn.1007–1096.2012.02.016.
[4]張雁, 徐佩松. 大隱靜脈高位結(jié)扎順行抽剝點(diǎn)式剝脫術(shù)的應(yīng)用價(jià)值[J]. 河北聯(lián)合大學(xué)學(xué)報(bào):醫(yī)學(xué)版, 2012, 14(2):216–217.doi:10.3969/j.issn.1008–6633.2012.02.056.Zhang Y, Xu PS. Application value of high ligation of the great saphenous vein, anterograde stripping and dot stripping[J]Journal of HeBei United University: Health Sciences, 2012, 14(2):216–217.doi:10.3969/j.issn.1008–6633.2012.02.056.
[5]Ekl?f B, Rutherford RB, Bergan JJ, et al. Revision of the CEAP classi fi cation for chronic venous disorders: consensus statement[J].J Vasc Surg, 2004, 40(6):1248–1252.
[6]Lin F, Zhang S, Sun Y, et al. The management of varicose veins[J]. Int Surg, 2015, 100(1):185–189. doi: 10.9738/INTSURG-D-14–00084.1.
[7]包磊, 漆興美, 謝光軍. 高位結(jié)扎聯(lián)合腔內(nèi)鈥激光治療大隱靜脈曲張的療效[J]. 實(shí)用臨床醫(yī)學(xué), 2014, 15(1):46–48.Bao L, Qi XM, Xie GJ. High Ligation Combined with Endovenous Holmium Laser Treatment for Great Saphenous Varicose Veins[J].Practical Clinical Medicine, 2014, 15(1):46–48.
[8]van den Boezem PB, Klem TM, le Cocq d'Armandville E, et al. The management of superficial venous incompetence[J]. BMJ, 2011,343:d4489. doi: 10.1136/bmj.d4489.
[9]劉小平, 郭偉, 賈鑫, 等. 內(nèi)翻剝脫加點(diǎn)式抽剝治療下肢靜脈曲張(附500例報(bào)告)[J]. 中國(guó)血管外科雜志:電子版, 2010, 2(3):166–168. doi:10.3969/j.issn.1674–7429.2010.03.010.Liu XP, Guo W, Jia X, et al. Treatment of varicose veins of the lower limbs by invaginated vein striping and ambulatory phlebectomy(a report of 500 cases)[J]. Chinese Journal of Vascular Surgery: Electronic Version, 2010, 2(3):166–168. doi:10.3969/j.issn.1674–7429.2010.03.010.
[10]Kostas TT, Ioannou CV, VeligrantakisM, et al. The appropriate length of great saphenous vein stripping should be based on the extent of reflux and not on the intent to avoid saphenous nerve injury[J]. J Vasc Surg, 2007, 46(6):1234–1241.
[11]中華醫(yī)學(xué)會(huì)外科學(xué)分會(huì)血管外科學(xué)組. 深靜脈血栓形成的診斷和治療指南[J]. 中華普通外科雜志, 2008, 23(3):235–238.doi:10.3760/j.issn:1007–631X.2008.03.032.Vascular Surgery Society, Surgery Branch of Chinese Medical Association. Guidelines for diagnosis and treatment of deep venous thrombosis[J]. Zhong Hua Pu Tong Wai Ke Za Zhi, , 2008,23(3):235–238. doi:10.3760/j.issn:1007–631X.2008.03.032.
[12]Winterborn RJ, Foy C, Earnshaw JJ. Causes of varicose vein recurrence:late results of a randomized controlled trial of stripping the long saphenous vein[J]. J Vasc Surg, 2004, 40(4):634–639.
[13]胡曉林, 李龍, 胡開(kāi)兵. 下肢靜脈曲張術(shù)后復(fù)發(fā)原因及手術(shù)方法探討[J]. 中華全科醫(yī)學(xué), 2010, 8(2):179–180.Hu XL, Li L, Hu KB. Cause and Treatment of the Recurrence of Varicose Veins after Varicotomy in Lower Extremity[J]. Chinese Journal of General Practice, 2010, 8(2):179–180.
[14]葸根, 陸雄. 低分子肝素鈣預(yù)防下肢靜脈曲張術(shù)后深靜脈血栓的價(jià)值[J]. 中國(guó)普通外科雜志, 2016, 25(12):1806–1809.doi:10.3978/j.issn.1005–6947.2016.12.023.Xi G, Lu X. Value of molecular weight heparin calcium in prevention of deep venous thrombosis after lower limb varicose vein operation[J]. Chinese Journal of General Surgery, 2016,25(12):1806–1809. doi:10.3978/j.issn.1005–6947.2016.12.023.
[15]彭程, 周智勇, 王凱, 等. 大隱靜脈高位結(jié)扎聯(lián)合導(dǎo)管泡沫硬化劑治療下肢靜脈曲張[J]. 中國(guó)血管外科雜志:電子版, 2014,6(2):107–109. doi:10.3969/j.issn.1674–7429.2014.02.013.Peng C, Zhou ZY, Wang K, et al. High ligation of great saphenous vein combined with catheter foam sclcrotherapy in varicose veins[J]. Chinese Journal of Vascular Surgery:Electronic Version,2014, 6(2):107–109. doi:10.3969/j.issn.1674–7429.2014.02.013.
[16]Ito T, Kukino R, Takahara M, et al. The wound/burn guidelines- 5: Guidelines for the management of lower leg ulcers/varicose veins[J]. J Dermatol, 2016, 43(8):853–868. doi: 10.1111/1346–8138.13286.
[17]Murad MH, Coto-Yglesias F, Zumaeta-Garcia M, et al. A systematic review and meta-analysis of the treatments of varicose veins[J]. J Vasc Surg, 2011, 53(5 Suppl):49S–65S. doi: 10.1016/j.jvs.2011.02.031.
[18]成偉, 吳章敏, 唐小斌, 等. 標(biāo)準(zhǔn)大隱靜脈剝脫術(shù)技術(shù)改進(jìn)(附336例報(bào)告)[J]. 中國(guó)實(shí)用外科雜志, 2012, 32(4):335–336.Cheng W, Wu ZM, Tang XB, et al. Modification of high ligation and stripping in the treatment of the great saphenous vein varicoses:a report of 336 patients[J]. Chinese Journal of Practical Surgery,2012, 32(4):335–336.
[19]Scheltinga MR, Wijburg ER, Keulers BJ, et al. Conventional versus invaginated stripping of the great saphenous vein: a randomized,double-blind, controlled clinical trial[J]. World J Surg, 2007,31(11):2236–2242.
[20]Rhodes JM, Gloviczki P. Endoscopic perforating vein surgery[J].Surg Clin North Am, 1999, 79((3):667–681.
[21]Rudstr?m H, Bergqvist D, Ahlberg J, et al. Insurance claims after vascular surgery in Sweden [J]. Eur J Vasc Endovasc Surg, 2011,42(4):498–505. doi: 10.1016/j.ejvs.2011.04.026.
[22]Perkins JM. Standard varicose vein surgery[J]. Phlebology, 2009,24 (Suppl 1):34–41. doi: 10.1258/phleb.2009.09s004.
[23]Testroote MJ, Wittens CH. Prevention of venous thromboembolism in patients undergoing surgical treatment of varicose veins[J]. Phlebology, 2013, 28(Suppl 1):86–90. doi:10.1177/0268355512475121.
[24]Campbell WB, Ridler BM. Varicose vein surgery and deep vein thrombosis[J]. Br J Surg, 1995, 82(11):1494–1497.
[25]Wang H, Sun Z, Jiang W, et al. Postoperative prophylaxis of venous thromboembolism (VTE) in Patients undergoing high ligation and stripping of the great saphenous vein (GSV)[J]. Vasc Med, 2015,20(2):117–121. doi: 10.1177/1358863X14564592.
[26]張昌明, 張福先, 張歡, 等. 大隱靜脈曲張術(shù)后復(fù)發(fā)病因分析:附63例報(bào)告[J]. 中國(guó)普通外科雜志, 2013, 22(12):1640–1642.doi:10.7659/j.issn.1005–6947.2013.12.024.Zhang CM, Zhang FX, Zhang H. Causes of the recurrence of varicose veins after varicotomy of great saphenous vein: a report of 63 cases[J]. Chinese Journal of General Surgery, 2013,22(12):1640–1642. doi:10.7659/j.issn.1005–6947.2013.12.024.